Genetic susceptibility to obstructive sleep apnea in the obese child

Sleep Medicine

Volumn 8, Issue 2, 2007, Pages 169-175

  Kalra, Maninder ^a   Chakraborty, Ranajit ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Central adiposity; Childhood obesity; Childhood OSA; Gene environment interaction; Intermediate phenotypes of OSA

Indexed keywords

CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; DISEASE ASSOCIATION; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MORBIDITY; OBESITY; PATHOGENESIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SLEEP APNEA SYNDROME;

APOLIPOPROTEIN E4; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OBESITY; PHENOTYPE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 33846828395     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.09.003     Document Type: Review

References (63)

1. Malhotra A., and White D.P. Obstructive sleep apnoea. Lancet 360 9328 (2002) 237-245
2. Mallory Jr. G.B., Fiser D.H., and Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr 115 6 (1989) 892-897
3. Kalra M., Inge T., Garcia V., Daniels S., Lawson L., Curti R., et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res 13 7 (2005) 1175-1179
4. Amin R.S., Carroll J.L., Jeffries J.L., Grone C., Bean J.A., Chini B., et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 169 8 (2004) 950-956
5. Amin R.S., Kimball T.R., Bean J.A., Jeffries J.L., Willging J.P., Cotton R.T., et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165 10 (2002) 1395-1399
6. Gozal D. Morbidity of obstructive sleep apnea in children: facts and theory. Sleep Breath 5 1 (2001) 35-42
7. de la Eva R.C., Baur L.A., Donaghue K.C., and Waters K.A. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 140 6 (2002) 654-659
8. Arens R., McDonough J.M., Corbin A.M., Rubin N.K., Carroll M.E., Pack A.I., et al. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 167 1 (2003) 65-70
9. Schwab R.J., Pasirstein M., Pierson R., Mackley A., Hachadoorian R., Arens R., et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 168 5 (2003) 522-530
10. Lam B., Ooi C.G., Peh W.C., Lauder I., Tsang K.W., Lam W.K., et al. Computed tomographic evaluation of the role of craniofacial and upper airway morphology in obstructive sleep apnea in Chinese. Respir Med 98 4 (2004) 301-307
11. Cakirer B., Hans M.G., Graham G., Aylor J., Tishler P.V., and Redline S. The relationship between craniofacial morphology and obstructive sleep apnea in whites and in African-Americans. Am J Respir Crit Care Med 163 4 (2001) 947-950
12. Fregosi R.F., Quan S.F., Kaemingk K.L., Morgan W.J., Goodwin J.L., Cabrera R., et al. Sleep-disordered breathing, pharyngeal size and soft tissue anatomy in children. J Appl Physiol 95 5 (2003) 2030-2038
13. Miles P.G., Vig P.S., Weyant R.J., Forrest T.D., and Rockette Jr. H.E. Craniofacial structure and obstructive sleep apnea syndrome-a qualitative analysis and meta-analysis of the literature. Am J Orthod Dentofacial Orthop 109 2 (1996) 163-172
14. Arens R., McDonough J.M., Costarino A.T., Mahboubi S., Tayag-Kier C.E., Maislin G., et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 164 4 (2001) 698-703
15. Horner R.L., Mohiaddin R.H., Lowell D.G., Shea S.A., Burman E.D., Longmore D.B., et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 2 7 (1989) 613-622
16. Schafer H., Pauleit D., Sudhop T., Gouni-Berthold I., Ewig S., and Berthold H.K. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122 3 (2002) 829-839
17. Schwartz A.R., Gold A.R., Schubert N., Stryzak A., Wise R.A., Permutt S., et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 144 3 Pt 1 (1991) 494-498
18. Katz E.S., and White D.P. Genioglossus activity in children with obstructive sleep apnea during wakefulness and sleep onset. Am J Respir Crit Care Med 168 6 (2003) 664-670
19. Mezzanotte W.S., Tangel D.J., and White D.P. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 89 5 (1992) 1571-1579
20. Mezzanotte W.S., Tangel D.J., and White D.P. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med 153 6 Pt 1 (1996) 1880-1887
21. Arens R., Sin S., McDonough J.M., Palmer J.M., Dominguez T., Meyer H., et al. Changes in upper airway size during tidal breathing in children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 171 11 (2005) 1298-1304
22. Jennum P., and Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1 4 (1992) 240-244
23. Kalra M., Lemasters G., Bernstein D., Wilson K., Levin L., Cohen A., et al. Atopy as a risk factor for habitual snoring at age 1 year. Chest 129 4 (2006) 942-946
24. Redline S., Tishler P.V., Tosteson T.D., Williamson J., Kump K., Browner I., et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 151 3 Pt 1 (1995) 682-687
25. Schwab R.J., Pasirstein M., Kaplan L., Pierson R., Mackley A., Hachadoorian R., et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med 173 4 (2006) 453-463
26. Guilleminault C., Partinen M., Hollman K., Powell N., and Stoohs R. Familial aggregates in obstructive sleep apnea syndrome. Chest 107 6 (1995) 1545-1551
27. Mathur R., and Douglas N.J. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 122 3 (1995) 174-178
28. Palmer L.J., Buxbaum S.G., Larkin E., Patel S.R., Elston R.C., Tishler P.V., et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 72 2 (2003) 340-350
29. Palmer L.J., Buxbaum S.G., Larkin E.K., Patel S.R., Elston R.C., Tishler P.V., et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 169 12 (2004) 1314-1321
30. Gottlieb D.J., DeStefano A.L., Foley D.J., Mignot E., Redline S., Givelber R.J., et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the sleep heart health study. Neurology 63 4 (2004) 664-668
31. Larkin E.K., Patel S.R., Redline S., Mignot E., Elston R.C., and Hallmayer J. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol 30 2 (2006) 101-110
32. Ewens W.J., and Spielman R.S. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 57 2 (1995) 455-464
33. Palmer L.J., and Redline S. Genomic approaches to understanding obstructive sleep apnea. Respir Physiol Neurobiol 135 2-3 (2003) 187-205
34. Itoh N., and Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet 20 11 (2004) 563-569
35. Hajihosseini M.K., Lalioti M.D., Arthaud S., Burgar H.R., Brown J.M., Twigg S.R., et al. Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131 2 (2004) 325-335
36. Morriss-Kay G.M., and Wilkie A.O. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 207 5 (2005) 637-653
37. Schwab R.J. Genetic determinants of upper airway structures that predispose to obstructive sleep apnea. Respir Physiol Neurobiol 147 2-3 (2005) 289-298
38. Fox C.S., Heard-Costa N.L., Wilson P.W., Levy D., D'Agostino Sr. R.B., and Atwood L.D. Genome-wide linkage to chromosome 6 for waist circumference in the Framingham heart study. Diabetes 53 5 (2004) 1399-1402
39. Strazzullo P., Iacone R., Iacoviello L., Russo O., Barba G., Russo P., et al. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the olivetti prospective heart study. Ann Intern Med 138 1 (2003) 17-23
40. Siani A., Iacone R., Russo O., Barba G., Russo P., Cappuccio F.P., et al. Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res 9 11 (2001) 722-726
41. Perusse L., Rice T., Chagnon Y.C., Despres J.P., Lemieux S., Roy S., et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec family study. Diabetes 50 3 (2001) 614-621
42. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 103 17 (2006) 6676-6681
43. Perusse L., Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., et al. The human obesity gene map: the 2004 update. Obes Res 13 3 (2005) 381-490
44. Snyder E.E., Walts B., Perusse L., Chagnon Y.C., Weisnagel S.J., Rankinen T., et al. The human obesity gene map: the 2003 update. Obes Res 12 3 (2004) 369-439
45. Agarwal A.K., and Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87 1 (2002) 408-411
46. Lehrke M., and Lazar M.A. The many faces of PPAR gamma. Cell 123 6 (2005) 993-999
47. Hegele R.A., Cao H., Frankowski C., Mathews S.T., and Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51 12 (2002) 3586-3590
48. Al-Shali K., Cao H., Knoers N., Hermus A.R., Tack C.J., and Hegele R.A. A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy. J Clin Endocrinol Metab 89 11 (2004) 5655-5660
49. Semple R.K., Chatterjee V.K., and O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 116 3 (2006) 581-589
50. Jaziri R., Lobbens S., Aubert R., Pean F., Lahmidi S., Vaxillaire M., et al. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the data from an epidemiological study on the insulin resistance syndrome (DESIR) study. Diabetes 55 4 (2006) 1157-1162
51. Weisgraber K.H., Roses A.D., and Strittmatter W.J. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5 2 (1994) 110-116
52. O'Donnell C.P., Tankersley C.G., Polotsky V.P., Schwartz A.R., and Smith P.L. Leptin, obesity, and respiratory function. Respir Physiol 119 2-3 (2000) 163-170
53. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 6 (1986) 1173-1182
54. Selinger-Leneman H., Genin E., Norris J.M., and Khlat M. Does accounting for gene-environment (G × E) interaction increase the power to detect the effect of a gene in a multifactorial disease?. Genet Epidemiol 24 3 (2003) 200-207
55. Towne B., Siervogel R.M., and Blangero J. Effects of genotype-by-sex interaction on quantitative trait linkage analysis. Genet Epidemiol 14 6 (1997) 1053-1058
56. Comuzzie A.G., Blangero J., Mahaney M.C., Haffner S.M., Mitchell B.D., Stern M.P., et al. Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. J Clin Endocrinol Metab 81 2 (1996) 597-600
57. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 291 5507 (2001) 1304-1351
58. The international HapMap project. Nature 2003; 426 (6968): 789-96.
59. Chanock S. Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers 17 2 (2001) 89-98
60. Hooper-van Veen T., Berkhof J., Polman C.H., and Uitdehaag B.M. Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis. Immunogenetics (2006)
61. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 6788 (2000) 847-856
62. Woo D., Kaushal R., Chakraborty R., Woo J., Haverbusch M., Sekar P., et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 36 9 (2005) 1874-1879
63. Redline S., Tishler P.V., Schluchter M., Aylor J., Clark K., and Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159 5 Pt 1 (1999) 1527-1532